These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30478786)

  • 1. ANXA2 expression in African American triple-negative breast cancer patients.
    Gibbs LD; Chaudhary P; Mansheim K; Hare RJ; Mantsch RA; Vishwanatha JK
    Breast Cancer Res Treat; 2019 Feb; 174(1):113-120. PubMed ID: 30478786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
    Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
    Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.
    Koh M; Lim H; Jin H; Kim M; Hong Y; Hwang YK; Woo Y; Kim ES; Kim SY; Kim KM; Lim HK; Jung J; Kang S; Park B; Lee HB; Han W; Lee MS; Moon A
    Autophagy; 2024 Mar; 20(3):659-674. PubMed ID: 38290972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
    O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
    Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.
    Gibbs LD; Vishwanatha JK
    Oncotarget; 2018 Jan; 9(2):2697-2704. PubMed ID: 29416802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong association of fascin expression with triple negative breast cancer and basal-like phenotype in African-American women.
    Esnakula AK; Ricks-Santi L; Kwagyan J; Kanaan YM; DeWitty RL; Wilson LL; Gold B; Frederick WA; Naab TJ
    J Clin Pathol; 2014 Feb; 67(2):153-60. PubMed ID: 23986556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANXA2 could act as a moderator of EGFR-directed therapy resistance in triple negative breast cancer.
    Zhang Y; Bi J; Zhu H; Shi M; Zeng X
    Biosci Biotechnol Biochem; 2018 Oct; 82(10):1733-1741. PubMed ID: 29912633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
    Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
    BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Annexin A2 Expression in Breast Cancer Patients.
    Gibbs LD; Mansheim K; Maji S; Nandy R; Lewis CM; Vishwanatha JK; Chaudhary P
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer.
    Uzelac B; Krivokuca A; Brankovic-Magic M; Magic Z; Susnjar S; Milovanovic Z; Supic G
    Pathol Oncol Res; 2020 Oct; 26(4):2723-2731. PubMed ID: 32681437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic features of Annexin A2 expression in prostate cancer.
    Tan SH; Young D; Chen Y; Kuo HC; Srinivasan A; Dobi A; Petrovics G; Cullen J; Mcleod DG; Rosner IL; Srivastava S; Sesterhenn IA
    Pathology; 2021 Feb; 53(2):205-213. PubMed ID: 32967771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profile of triple-negative breast cancer in African-American women reveals potential biomarkers of aggressive disease.
    Kanaan YM; Sampey BP; Beyene D; Esnakula AK; Naab TJ; Ricks-Santi LJ; Dasi S; Day A; Blackman KW; Frederick W; Copeland RL; Gabrielson E; Dewitty RL
    Cancer Genomics Proteomics; 2014; 11(6):279-94. PubMed ID: 25422359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.
    Jiagge E; Jibril AS; Chitale D; Bensenhaver JM; Awuah B; Hoenerhoff M; Adjei E; Bekele M; Abebe E; Nathanson SD; Gyan K; Salem B; Oppong J; Aitpillah F; Kyei I; Bonsu EO; Proctor E; Merajver SD; Wicha M; Stark A; Newman LA
    Ann Surg Oncol; 2016 Nov; 23(12):3843-3849. PubMed ID: 27469125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulator of G protein signaling 20 correlates with clinicopathological features and prognosis in triple-negative breast cancer.
    Li Q; Jin W; Cai Y; Yang F; Chen E; Ye D; Wang Q; Guan X
    Biochem Biophys Res Commun; 2017 Apr; 485(3):693-697. PubMed ID: 28237701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
    Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
    Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5α-Epoxyalantolactone Inhibits Metastasis of Triple-Negative Breast Cancer Cells by Covalently Binding a Conserved Cysteine of Annexin A2.
    Wei M; Zhou Y; Li C; Yang Y; Liu T; Liu Y; Wei Y; Liu N; Liu S; Wang Q; Cao S; Sun Y; Sheng P; Lu C; Yang C; Liu X; Yang G
    J Med Chem; 2021 Sep; 64(17):12537-12547. PubMed ID: 34351142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biomarkers for prediction of response to treatment and survival in triple negative breast cancer patients from Egypt.
    Bahnassy A; Mohanad M; Ismail MF; Shaarawy S; El-Bastawisy A; Zekri AR
    Exp Mol Pathol; 2015 Oct; 99(2):303-11. PubMed ID: 26232605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.
    Newman LA; Stark A; Chitale D; Pepe M; Longton G; Worsham MJ; Nathanson SD; Miller P; Bensenhaver JM; Proctor E; Swain M; Patriotis C; Engstrom PF
    JAMA Oncol; 2017 Aug; 3(8):1102-1106. PubMed ID: 28006062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.
    Li X; Yang J; Peng L; Sahin AA; Huo L; Ward KC; O'Regan R; Torres MA; Meisel JL
    Breast Cancer Res Treat; 2017 Jan; 161(2):279-287. PubMed ID: 27888421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.